OXAZOLIDINONDERIVATE

European patent · EP2254887 · Deleted

Register entry

Publication number
EP2254887
Application number
EP09711588
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Feb 20, 2009
Published
Dec 1, 2010
Granted
Dec 19, 2012
Deleted
Feb 29, 2020
Reason
Annual fee unpaid
IPC classes
C07D 471/04 (2006.01)
C07D 413/14 (2006.01)
C07D 417/14 (2006.01)
C07D 519/00 (2006.01)
A61K 31/536 (2006.01)
A61K 31/4704 (2006.01)
A61K 31/498 (2006.01)
A61K 31/4985 (2006.01)
A61P 31/00 (2006.01)
Priority
WO PCT/IB2008/050651 22.02.2008
WO PCT/IB2008/054095 07.10.2008
PCT application
PCT/IB2009/050702 20.02.2009
PCT publication
WO2009/104159 27.08.2009
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 23, 2020

    Deleted, fee unpaid

    Published in Swissreg on 23.09.2020

  2. Sep 14, 2017

    Transferred

    Owner
    Actelion Pharmaceuticals Ltd., Gewerbestrasse 16, 4123 Allschwil → Idorsia Pharmaceuticals Ltd, Hegenheimermattweg 91, 4123 Allschwil

    Published in Swissreg on 14.09.2017

  3. Dec 19, 2012

    Granted

    Published in Swissreg on 19.12.2012

Parties

Holder

Idorsia Pharmaceuticals Ltd

Hegenheimermattweg 91, 4123 Allschwil

Inventor

HUBSCHWERLEN, Christian

F-68480 Durmenach, FR

RUEEDI, Georg

CH-4123 Allschwil

SURIVET, Jean-Philippe

F-68680 Kembs, FR

ZUMBRUNN ACKLIN, Cornelia

CH-4058 Basel

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.